Sr Assoc Scientist, Analytical Drug Product Development and Technology (1 of 2)
Regeneron Pharmaceuticals
Summary
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a highly motivated Sr. Associate Scientist to join our Drug Product Development and Technology (DPDT) group, supporting laboratory-based analytical method development and qualification. The DPDT team supports all stages of R&D work through commercialization. In this role, you will be responsible for developing and qualifying analytical methods for assessing drug product stability of various drug products from pre-clinical to commercial development.
Job description
What you'll do
- Develop analytical methods for a broad range of biologic drug products, including monoclonal and bispecific antibodies, antibody-drug conjugates, peptides, siRNA, mRNA-LNP, and AAV-based products
- Develop and qualify analytical methods for critical quality attributes to support formulation development, DP process development, and stability testing for programs in preclinical and clinical stage
- Prepare, author, and review critical analytical technical documents, including analytical method procedures (SOPs), method performance reports, method transfer documents, and contribute to pharmaceutical development reports for completeness and correctness
- Maintain full working knowledge of analytical techniques and instruments, applying them appropriately to projects, and identify and assess novel analytical methods and technologies
- Evaluate, interpret, and present data at team meetings
- Collaborate with other team members in DPDT and other functional groups at Regeneron in supporting program development
- Maintain accurate and complete laboratory records, participate in general lab instrument maintenance, and perform troubleshooting independently
The environment and physical rhythms of this role
- This is a laboratory environment requiring the ability to work independently to design experiments, as well as interpret, document, and communicate results
- Demonstrated communication skills, a collaborative attitude, and strong multi-tasking capabilities, to thrive in matrix teams, are required
Must-haves
- BS degree in Chemistry, Chemical Engineering, Biochemistry, or a related field with 6+ years of research experience, or MS degree in the above-mentioned fields with 3+ years of hands-on research experience
- Experience with quantitative and qualitative analytical techniques for biologic drug products, including liquid chromatography (LC) and capillary electrophoresis (CE)-based methods
- Ability to work independently to design experiments, as well as interpret, document, and communicate results
- Enthusiasm for science with a motivation for making contributions in a team environment
Preferred / nice-to-haves
- Experience with siRNA analytical methods
Requirements
- BS degree in Chemistry, Chemical Engineering, Biochemistry, or a related field with 6+ years of research experience, or MS degree in the above-mentioned fields with 3+ years of hands-on research experience
- Experience with quantitative and qualitative analytical techniques for biologic drug products, including liquid chromatography (LC) and capillary electrophoresis (CE)-based methods
- Ability to work independently to design experiments, as well as interpret, document, and communicate results
- Enthusiasm for science with a motivation for making contributions in a team environment
- Experience with siRNA analytical methods
Benefits
- Student Loan Paydown Program
- Tuition Reimbursement
- Family Care Benefits
- Relocation Assistance
- Inclusion, Culture & Well-Being Programs
- Annual Bonuses
- Equity Awards
- Pension/Retirement Benefits
- 401(k) Company Match
- Health & Wellness Programs
- Fitness Centers
- Insurance Benefits
- Paid Time Off
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.